Innocoll Holdings plc to Present at the Piper Jaffray Annual Healthcare Conference
23 nov. 2016 08h00 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, Nov. 23, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical and medical device company with late stage development programs targeting...
Innocoll Holdings plc Announces Third Quarter 2016 Financial and Operating Results and Provides Corporate Update
22 nov. 2016 08h00 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, Nov. 22, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
Innocoll to Report Third Quarter 2016 Financial Results and Host Webcast and Conference Call on November 22, 2016
15 nov. 2016 08h30 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, Nov. 15, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
Innocoll Holdings plc to Present at the Stifel 2016 Healthcare Conference
14 nov. 2016 08h30 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, Nov. 14, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical and medical device company with late stage development programs targeting...
Innocoll Announces Top-Line Data From Phase 3 Trials With COGENZIA and NDA Submission for XARACOLL
03 nov. 2016 16h31 HE
|
Innocoll Holdings plc
COACT-1 and COACT-2 Phase 3 clinical trials for COGENZIA did not achieve statistical significance in improving clinical cure in diabetic foot infections (DFI)New Drug Application (NDA) for XARACOLL...
Innocoll Holdings plc to Present at the Morgan Stanley Global Healthcare Conference
07 sept. 2016 16h01 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, Sept. 07, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical and medical device company with late stage development programs targeting...
Innocoll Holdings plc Announces Second Quarter 2016 Financial and Operating Results and Provides Corporate Update
17 août 2016 08h00 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, Aug. 17, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
Innocoll to Report Second Quarter 2016 Financial Results and Host Webcast and Conference Call on August 17, 2016
11 août 2016 16h01 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, Aug. 11, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
Innocoll Holdings plc to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
06 juil. 2016 09h00 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, July 06, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL) a global, specialty pharmaceutical and medical device company with late stage development programs targeting...
Innocoll Holdings plc Announces the Completion of Enrollment in Two Pivotal Phase 3 Clinical Trials of COGENZIA for the Treatment of Diabetic Foot Infections
23 juin 2016 09h00 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, June 23, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...